Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Provident Financial Services
PFS
$3.07B
| $1.85M | ﹤0.01% |
93,904
-4,930
| -5% | -$95.3K |
|
3902
CenterPoint Energy
CNP
$25.8B
| $1.85M | ﹤0.01% |
48,347
-5,800,404
| -99% | -$226M |
|
3903
CALL
Symbotic
SYM
$5.18B
| $1.85M | ﹤0.01% |
31,100
-18,100
| -37% | -$1.2M |
|
3904
Integra LifeSciences
IART
$1.31B
| $1.85M | ﹤0.01% |
148,971
-75,995
| -34% | -$1.01M |
|
3905
PUT
Fidelity National Information Services
FIS
$21.4B
| $1.85M | ﹤0.01% |
27,800
-7,900
| -22% | -$521K |
|
3906
Ameris Bancorp
ABCB
$5.74B
| $1.84M | ﹤0.01% |
24,838
-645,474
| -96% | -$48M |
|
3907
Marcus & Millichap
MMI
$1.23B
| $1.84M | ﹤0.01% |
67,388
-104,879
| -61% | -$3.03M |
|
3908
CALL
Blue Owl Capital
OWL
$8.22B
| $1.84M | ﹤0.01% |
122,900
+41,600
| +51% | +$650K |
|
3909
Coursera
COUR
$1.71B
| $1.84M | ﹤0.01% |
249,429
-422,983
| -63% | -$3.68M |
|
|
ALDF
3910
Aldel Financial II Inc
ALDF
$322M
| $1.84M | ﹤0.01% |
175,000
| – | – |
|
3911
Centuri Holdings
CTRI
$2.05B
| $1.83M | ﹤0.01% |
72,651
-1,192,486
| -94% | -$26.7M |
|
|
WRN
3912
Western Copper and Gold
WRN
$570M
| $1.83M | ﹤0.01% |
686,447
+433,420
| +171% | +$1M |
|
3913
Alvotech
ALVO
$1.77B
| $1.83M | ﹤0.01% |
357,176
+337,417
| +1,708% | +$2.13M |
|
|
MRSN
3914
DELISTED
Mersana Therapeutics
MRSN
| $1.83M | ﹤0.01% |
63,305
-14,684
| -19% | -$279K |
|
3915
CALL
Teleflex
TFX
$5.92B
| $1.83M | ﹤0.01% |
+15,000
| New | +$1.82M |
|
3916
Custom Truck One Source
CTOS
$2.09B
| $1.83M | ﹤0.01% |
+317,801
| New | +$1.94M |
|
3917
Immunic
IMUX
$210M
| $1.82M | ﹤0.01% |
341,930
+288,883
| +545% | +$2.12M |
|
3918
PUT
ADMA Biologics
ADMA
$2.09B
| $1.82M | ﹤0.01% |
+100,000
| New | +$1.69M |
|
|
NHIC
3919
NewHold Investment Corp III
NHIC
$293M
| $1.81M | ﹤0.01% |
175,000
| – | – |
|
3920
Frontline
FRO
$9.84B
| $1.81M | ﹤0.01% |
83,092
-430,050
| -84% | -$10.1M |
|
|
AVDL
3921
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.81M | ﹤0.01% |
84,085
-8,315
| -9% | -$161K |
|
3922
CALL
Darling Ingredients
DAR
$10.1B
| $1.81M | ﹤0.01% |
50,300
-12,500
| -20% | -$423K |
|
3923
Abeona Therapeutics
ABEO
$339M
| $1.81M | ﹤0.01% |
343,568
-365,781
| -52% | -$1.84M |
|
|
PKST
3924
DELISTED
Peakstone Realty Trust
PKST
| $1.81M | ﹤0.01% |
126,135
+4,341
| +4% | +$59.9K |
|
|
NVMI
3925
CALL
Nova
NVMI
$11.1B
| $1.81M | ﹤0.01% |
5,500
+2,700
| +96% | +$868K |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.